Feasibility of developing innovative processes to improve the manufacturing logistics of cell therapy

细胞疗法有望治疗许多疾病，然而，提供活细胞疗法的一个限制特征是产品的保质期相对较短。该项目旨在测试使用两种不同的、创新的工艺变化来显著延长保质期的可行性，这将极大地影响InterCytex的，可能还有其他公司生产细胞疗法的方式。该项目的成功将导致InterCytex进行更多的研究，使这一过程能够用于患者治疗。它将使该公司能够按需为临床医生准备好产品，用于治疗严重的水泡病、大疱性表皮松解症和疤痕挛缩症。

Cell Therapies hold the promise to treat a great many diseases, however one limiting feature of providing a living cell therapy is the realtively short shelf life of the products. This project aims to test the feasibility of using two different, innovative process changes to extend this shelf life considerably which would greatly impact how Intercytex's, and possibly others manufacture cell therapies. Success in this project will lead to additional studies by Intercytex to allow this process to be used for patient treatment. It will allow the Company to have product ready on demand for clinicans to treat the severe blistering disease Epidermolysis Bullosa and scar contractures.